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Pulmonary oligometastases are often resected for therapeutic pur-
poses [1]. The differential diagnosis between primary and secondary
malignancies in the lung is generally straightforward, with the excep-
tion of squamous cell carcinomas, which may be confused with head
and neck metastases [2], and rare multicentric primary lung tumors
that mimic metastatic disease [3].
A single case of delayed metastasis secondary to ureteral urothelial
carcinoma has been reported [4]. We report a similar case of urothelial
carcinoma of the bladder that mimicked a primary tumor, with the con-
founding presence of adjacent adenocarcinoma-in situ. To our knowl-
edge this is the ﬁrst such reported case.2. Case report
A 61 year-oldmale with a signiﬁcant smoking history is found on CT
imaging to have a 1.4 × 1.0 cm lobularmass in the left upper lobe suspi-
cious for primary lung neoplasm. The patient underwent surgery for a
primary lung tumor, includingwedge resection followed by completion
lobectomy and mediastinal lymph node dissection.
Five years prior, he had undergone adjuvant chemotherapy and rad-
ical cystoprostatectomy for high grade invasive urothelial carcinoma,
stage pT3b pN0. Lymphovascular invasion was present. Margins were
uninvolved, and the cancer was considered cured.
On gross examination, the wedge resection specimen (7.9 × 3.2
× 1.4 cm) showed a ﬁrm heterogeneous tan-brown nodule measuring
1.5 cm in greatest dimension and grossly abutting the pleura. Anintraoperative frozen section was performed and diagnosed as poorly
differentiated carcinoma, favor urothelial. Postoperative pathologic ex-
amination revealed the mass to be a poorly differentiated carcinoma
(blue insert in Fig. 1) with an adjacent 2 mm focus of adenocarcinoma
in situ (red insert in Fig. 1). While the 2 mm lesion is small enough to
meet criteria for the diagnosis of atypical adenomatous hyperplasia,
the atypia and nuclear pleomorphism of the cells in the 2 mm lesion
were more consistent with the morphology of adenocarcinoma in situ.
The poorly differentiated carcinoma was negative for TTF-1, napsin,
CK7, p40, p63, and uroplakin, while expressing positivity for GATA-3.
The 2 mm focus of adenocarcinoma in situ was positive for TTF-1 and
CK7, and negative for GATA-3 (Figs. 2 and 3).
3. Discussion
Pulmonary metastasis is seen in 20% of patients with recurrent
urothelial carcinoma of the bladder [5]. Approximately 80%–90% are di-
agnosed in the ﬁrst 3 years after diagnosis of the primary tumor. The
majority occur at the time of cystectomy or in the ﬁrst 24 months, at a
median interval of 16 months [6,7]. Risk factors for systemic recurrence
include a pathologic stage of pT3 or pT4, and the presence of positive
margins and lymph node metastases [6].
The ﬁnal diagnosis of the poorly differentiated carcinomawas large-
ly based onGATA-3 positivity. Reports have shownGATA-3 to be a high-
ly sensitive (N80%) marker of urothelial carcinomas, however, rare
poorly differentiated adenocarcinomas of the lung have demonstrated
GATA-3 positivity in 40–60% of cells [8].
Only 25% of metastatic urothelial carcinomas occur as single lung
nodules [9]. Because of their infrequent presentation as single lesions,
urothelial carcinomas represent only 1% of surgically resected pulmo-
nary oligometastases of all primary sites [10]. However, the lung is the
most common site for oligometastases arising from the bladder
Fig. 1. Metastatic urothelial carcinoma adjacent to lung adenocarcinoma in situ
(Hematoxylin and eosin stain).
Fig. 3. Left: Positive GATA-3 immunostaining in both carcinoma cells (left) and adjacent
tumor inﬁltrating lymphocytes (right).
2 S. Shyu et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxurothelium [9]. Late onset pulmonarymetastases are exceptionally rare,
and have been reported for urothelial carcinomas of the upper
urothelial tract as single case reports [4].
In this report, we describe the evaluation of a patient with a distant
history of bladder carcinoma with a new lung mass, ultimately consis-
tent with metastatic growth of urothelial carcinoma, coexisting with
an adjacent incidental microscopic focus of primary lung adenocarcino-
ma in situ. Since metastatic bladder cancer was initially not strongly
considered in the differential diagnosis, the presence of the minute
focus of pulmonary adenocarcinoma in situ could lead to erroneously
diagnosing the entire lesion as primary lung adenocarcinoma. This
case raises two issues of practical and academic signiﬁcance: (a) the im-
portance of immunohistochemistry in the diagnosis of lung tumors, and
(b) the possibility of concurrent neoplasms of different origins in adja-
cent/collision sites. The latter possibility has been previously reported
in lung tumors [11]. Poorly differentiated carcinomas of the lung can
also be an especial challenge to diagnose on frozen section regarding
the distinction between primary and metastatic lesions, and ﬁndings
in such cases should be communicated to the surgeon to convey the lim-
itations of frozen section evaluation [12]. A high index of suspicion for
pulmonary metastatic involvement should therefore be maintained,
even in the presence of adjacent pulmonary carcinoma in situ.Fig. 2. Left: Positive TTF-1 immunostaining in lung adenocarcinoma in situ (Insert: TTF-1 nega
Positive GATA-3 in metastatic urothelial carcinoma (Insert: GATA-3 negative lung adenocarcin
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